MAK683
CAS No. 1951408-58-4
MAK683 ( MAK-683;MAK683 )
Catalog No. M13052 CAS No. 1951408-58-4
MAK683 (MAK-683) is a novel inhibitor of embryonic ectoderm development protein (EED) and allosteric inhibitor of polycomb repressive complex 2 (PRC2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 98 | Get Quote |
|
10MG | 178 | Get Quote |
|
25MG | 390 | Get Quote |
|
50MG | 574 | Get Quote |
|
100MG | 803 | Get Quote |
|
500MG | 1665 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMAK683
-
NoteResearch use only, not for human use.
-
Brief DescriptionMAK683 (MAK-683) is a novel inhibitor of embryonic ectoderm development protein (EED) and allosteric inhibitor of polycomb repressive complex 2 (PRC2).
-
DescriptionMAK683 (MAK-683) is a novel inhibitor of embryonic ectoderm development protein (EED) and allosteric inhibitor of polycomb repressive complex 2 (PRC2), selectively binds to the domain of EED that interacts with H3K27me3; leads to a conformational change in the EED H3K27me3-binding pocket and prevents the interaction of EED with the histone methyltransferase enhancer zeste homolog 2 (EZH2), inhibits tumor cell proliferation in EZH2-mutated and PRC2-dependent cancer cells.Blood Cancer Phase 2 Clinical
-
SynonymsMAK-683;MAK683
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1951408-58-4
-
Formula Weight376.39
-
Molecular FormulaC20H17FN6O
-
Purity>98% (HPLC)
-
SolubilityDMSO : 52 mg/mL 138.15 mM; H2O : < 0.1 mg/mL
-
SMILESCC1=C(C=CC=N1)C2=CN=C(N3C2=NN=C3)NCC4=C(C=CC5=C4CCO5)F
-
Chemical NameN-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(2-methylpyridin-3-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
UNC0379 trifluoroace...
UNC0379 is a selective, +N2106:AC2106substrate-competitive inhibitor of lysine methyltransferase SETD8 with IC50 of 7.3 uM.
-
BCI-121
BCI-121 (BCI121) is a substrate-competitive SMYD3 inhibitor.
-
EBI-2511
EBI-2511 is a highly potent and orally active EZH2 inhibitor with IC50 of 4 nM against mutant EZH2 A677G.